The Medical Letter on Drugs and Therapeutics
October 11, 2004
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Duloxetine (Cymbalta): A New SNRI for Depression
October 11, 2004 (Issue: 1193)Duloxetine hydrochloride (Cymbalta - Lilly), a selective serotonin and norepinephrine reuptake inhibitor (SNRI), has been approved by the FDA for treatment of major depressive disorder in adults, and more recently for diabetic peripheral neuropathy...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.